We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $15.6B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
Cap. Flow
+$206M
Cap. Flow %
1.46%
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$134M
2
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$120M
3
KKR icon
KKR & Co
KKR
+$113M
4
MDLZ icon
Mondelez International
MDLZ
+$103M
5
AXS icon
AXIS Capital
AXS
+$97.1M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$303M
2
BSX icon
Boston Scientific
BSX
+$127M
3
LEN icon
Lennar Class A
LEN
+$95.9M
4
MLM icon
Martin Marietta Materials
MLM
+$94.6M
5
CL icon
Colgate-Palmolive
CL
+$92M

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.39%
3 Miscellaneous 12.72%
4 Industrials 12.27%
5 Healthcare 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARQT icon
801
Arcutis Biotherapeutics
ARQT
$2.99B
$107K ﹤0.01%
+4,543
New +$116K
SSD icon
802
Simpson Manufacturing
SSD
$7.46B
$102K ﹤0.01%
+594
New +$110K
AZTA icon
803
Azenta
AZTA
$1.44B
$99.3K ﹤0.01%
+4,698
New +$140K
CERT icon
804
Certara
CERT
$1.27B
$98.7K ﹤0.01%
+17,312
New +$132K
GO icon
805
Grocery Outlet
GO
$1.21B
$98.6K ﹤0.01%
13,989
-679
-5% -$5.9K
BLFS icon
806
BioLife Solutions
BLFS
$1.78B
$98.5K ﹤0.01%
+5,163
New +$114K
ADTN icon
807
Adtran
ADTN
$629M
$97.3K ﹤0.01%
7,731
-2,291
-23% -$23.2K
NAMS icon
808
NewAmsterdam Pharma
NAMS
$3.1B
$96K ﹤0.01%
+3,000
New +$97.7K
DELL icon
809
Dell
DELL
$295B
$95.4K ﹤0.01%
+581
New +$77.4K
ARLO icon
810
Arlo Technologies
ARLO
$1.39B
$92.5K ﹤0.01%
6,501
-21,290
-77% -$285K
SBAC icon
811
SBA Communications
SBAC
$20.3B
$90.9K ﹤0.01%
+528
New +$99K
WAFD icon
812
WaFd
WAFD
$2.67B
$90.6K ﹤0.01%
+2,886
New +$92.8K
HLIT icon
813
Harmonic Inc
HLIT
$1.31B
$88.8K ﹤0.01%
+9,888
New +$98.2K
AMRC icon
814
Ameresco
AMRC
$1.17B
$87.7K ﹤0.01%
+3,440
New +$103K
CHEF icon
815
Chefs' Warehouse
CHEF
$4.69B
$86.9K ﹤0.01%
+1,461
New +$93.5K
KRUS icon
816
Kura Sushi USA
KRUS
$577M
$82.5K ﹤0.01%
+1,182
New +$79.3K
ABUS icon
817
Arbutus Biopharma
ABUS
$1B
$81K ﹤0.01%
+18,006
New +$78.7K
CDNA icon
818
CareDx
CDNA
$2.58B
$76.7K ﹤0.01%
+4,416
New +$83.6K
XPEL icon
819
XPEL
XPEL
$1.37B
$74.5K ﹤0.01%
+1,683
New +$80.4K
XHR
820
Xenia Hotels & Resorts
XHR
$1.8B
$73.3K ﹤0.01%
+4,941
New +$74.4K
GCT icon
821
GigaCloud Technology
GCT
$1.89B
$72.3K ﹤0.01%
+1,594
New +$64.8K
IMKTA icon
822
Ingles Markets
IMKTA
$1.56B
$70.6K ﹤0.01%
+785
New +$63.6K
CRMD icon
823
CorMedix
CRMD
$647M
$70.2K ﹤0.01%
+10,332
New +$76.4K
NWN icon
824
Northwest Natural Holdings
NWN
$2.08B
$68.2K ﹤0.01%
+1,282
New +$63.5K
LBRT icon
825
Liberty Energy
LBRT
$3.1B
$67.6K ﹤0.01%
2,346
-345,879
-99% -$8.82M
31 32
33
34 35

Similar funds

ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Freestone Grove Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.

  • Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
  • Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
  • Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
  • Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
  • Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
  • Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
  • Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.